Skip to main content

Pericarditis caused by Mycobacterium africanum: case report

Abstract

Background

Mycobacterium africanum is a member of the Mycobacterium tuberculosis complex (MTBC) and is endemic in West Africa, where it causes up to half of all cases of pulmonary tuberculosis. Here, we report the first isolation of Mycobacterium africanum from the pericardial effusion culture of a patient with tuberculous pericarditis.

Case presentation

A 31-year-old man, native from Senegal, came to the emergency room with massive pericardial effusion and cardiac tamponade requiring pericardiocentesis. M. africanum subtype II was identified in the pericardial fluid. The patient completed 10 months of standard treatment, with a favorable outcome.

Conclusions

We report the first case of tuberculous pericarditis caused by Mycobacterium africanum, which provide evidence that this microorganism can cause pericardial disease and must be considered in patients from endemic areas presenting with pericardial effusion.

Peer Review reports

Background

Mycobacterium africanum (M. africanum) is a member of the Mycobacterium tuberculosis complex (MTBC) and a primary cause of human tuberculosis disease globally [1]. The MTBC consists of seven phylogenetically distinct lineages (L1–L7) and the phylogenetic study of M. africanum classifies it into two groups of different biochemical characteristics and geographical origin: M. africanum subtype I (L5) and M. africanum subtype II (L6) [2, 3].

M. africanum is endemic in West Africa, where it causes up to half of all cases of pulmonary tuberculosis [4]. In developed countries, cases are mostly restricted to migrants from endemic areas [5]. Although the pulmonary form has predominantly been described, some cases of extrapulmonary presentations (pleural,cutaneous, bone, cerebral, prostatitis or epididymitis) have been published [6,7,8,9,10,11]. To the best of our knowledge, no cases of pericardial involvement have ever been reported.

We describe the first case of tuberculous pericarditis caused by M. africanum. The patient presented with massive pericardial effusion and cardiac tamponade requiring pericardiocentesis and M. africanum subtype II was identified in the pericardial fluid.

Case presentation

A 31-year-old man, native from Senegal and living in Spain for one year, came to the emergency room reporting non-productive cough, asthenia, evening fever and profuse sweating of one month duration, with progressive dyspnea limiting ordinary activity from the day before admission.

Patient’s condition met the Beck’s triad including arterial hypotension (a blood pressure of 85/65 mmHg), muffled heart sounds and mild jugular engorgement.

Chest X-ray (Fig. 1) and computed tomography (Fig. 2) revealed a significant increase in the cardiac silhouette with bilateral pleural effusion and without pulmonary lesions. The electrocardiogram showed a heart rate of 100 beats per minute, with low voltage, a right bundle branch block and electrical alternans.

Fig. 1
figure 1

Chest x-ray showing a significant increase in the cardiac silhouette with bilateral pleural effusion without pulmonary lesions

Fig. 2
figure 2

Chest computed tomography showing a massive pericardial effusion

Transthoracic echocardiography described severe pericardial effusion with echocardiographic signs of hemodynamic compromise, right ventricular diastolic collapse, and right atrium systolic collapse, as well as a dilated inferior vena cava and global hypokinesia that conditioned a severely depressed left ventricular ejection fraction (30%) (Fig. 3).

Fig. 3
figure 3

Transthoracic echocardiography showing a massive pericardial effusion

To investigate the etiology of pericardial effusion and cardiac tamponade, an ultrasound-guided percutaneous puncture pericardiocentesis and pericardial biopsy with a pericardioscope through the subxiphoid route were performed. Pericardial effusion had serohematic appearance and the cytochemical and cytological study showed increased cells, predominantly lymphocytes and macrophages, with elevated adenosine deaminase levels (120,2 U/L). Conventional bacteriologic cultures of pericardial effusion were negative. Acid-alcohol-fast bacilli were not observed in the Ziehl-Neelsen stain. The pericardial sample was processed for culture in liquid medium (Bactec MGIT 960) and in enriched solid medium (Coletsos and Löwenstein-Jensen). Since only one sample was available for all microbiological processes, direct PCR and liquid culture were performed from the same sample. The direct MTBC PCR (FluoroTypeMTB-Hain) from the pericardial effusion was negative. Liquid medium culture was positive for mycobacteria after seven weeks of incubation, and PCR performed at this moment from this liquid medium was also positive for MTBC. Rapid confirmation of presumptive positive liquid cultures of Mycobacterium tuberculosis, based on the detection of the MPT64 antigen, was negative from the liquid medium, but positive from direct colony.

The strain was sent to the Mycobacteria Laboratory of the National Center for Microbiology (Carlos III Health Institute), where it was identified as M. africanum, and it showed to be sensitive to isoniazid, rifampin, pyrazinamide, streptomycin, and ethambutol.

Genomic epidemiologic analysis was carried out (Tuberculosis Genomics Unit of the Biomedicine Institute of Valencia) using the whole genome sequencing technique for a subsequent genomic analysis of single nucleotide point mutations (SNP). The species and lineage identified were M. africanum subtype II. The analysis of genetic distances showed it was a single sample, not belonging to any transmission group of the Valencian Community included in the Tuberculosis Genomics Unit’s database. The strain was found at a distance greater than 300 SNPs from the closest strain. No specific SNPs were identified that confirmed resistance to the different first and second line antituberculosis drugs.

IFN-γ production was determined by QuantiFERON-TB Gold Plus (QFT-Plus) in the patient’s blood using ESAT-6 and CFP-10 antigens and was negative.

Pericardial biopsy revealed non-necrotizing chronic granulomatous pericarditis.

The HIV serology test was negative.

Antituberculous therapy including isoniazid, rifampin, ethambutol, and pyrazinamide was started, as well as adjuvant treatment with corticosteroids.

The patient was switched to isoniazid and rifampicin after an initial two-month regimen with four drugs and completed 10 months of therapy, with a favorable outcome. The patient underwent periodic transthoracic echocardiograms. One month after hospital admission, the pericardial effusion had improved, and a preserved left ventricular ejection fraction was observed.

Discussion and conclusions

Pericarditis is a rare manifestation of tuberculosis that carries high morbidity and mortality despite proper diagnosis and treatment. Tuberculous etiology represents less than 4% of all cases of pericarditis in developed countries [12]. The pericardium is affected by contiguity from the peritracheal, peribronchial and mediastinal nodes, or by the hematogenous route from pulmonary tuberculosis.

Although pulmonary and extrapulmonary tuberculosis caused by M. africanum have been reported, this is the first ever-reported case of pericardial involvement, causing tuberculous pericarditis with cardiac tamponade. M. africanum infrequently causes tuberculosis infection in Spain. Tuberculosis disease caused by M. africanum is more frequently associated with elderly patients, severe malnutrition, HIV infection and with severe abnormal radiological findings in the X-ray [13]. M. africanum induces similar clinical manifestations to the rest of mycobacteria belonging to the MTBC, although it has lower virulence and lower rate of progression to active tuberculosis than M. tuberculosis [14]. M. africanum lineages show microaerobic growth and are usually associated with extrapulmonary disease, which suggests a preference for regions with low oxygen [15].

Crucial virulence mechanisms have been shown to be altered in M. africanum infection, including an attenuation of T-cell responses to the mycobacterial-secreted antigenic and virulence factor ESAT-6, that could impair the accuracy of interferon-gamma release assays (IGRA) [16]. This would explain the negative results of the QuantiFERON-TB Gold Plus test observed in our patient.

Interferon-gamma release assays have recently shown promising results in diagnosing active extrapulmonary tuberculosis. The T-SPOT.TB has shown a high sensitivity and specificity on tuberculosis pericardial effusion [17]. Therefore, these tests appear to be a promising rapid diagnostic method with high diagnostic accuracy for diagnosis of tuberculous pericarditis [18].

M. africanum grows more slowly than M. tuberculosis; it can take up to 10 weeks to yield growth in cultures [19].

Regarding treatment, M. africanum infections respond to regular tuberculosis treatment. Adjuvant steroid treatment has been associated with a decrease in the incidence of pericardial constriction and hospitalization in mycobacterial pericarditis [20].

In conclusion, M. africanum can cause pericardial disease and must be considered in patients from endemic areas presenting with pericardial effusion. The diagnosis may be challenging due to the longer growth time than M. tuberculosis and the fact that the disease is less likely to have a positive IGRA result. These difficulties become more relevant in areas where there is a greater distribution of M. africanum and sometimes with fewer available resources, as in the case of Africa.

Availability of data and materials

Not applicable.

Abbreviations

MTBC:

Mycobacterium tuberculosis complex

M. africanum :

Mycobacterium africanum

PCR:

Polymerase chain reaction

SNP:

single nucleotide point mutations

IGRA:

interferon-gamma release assays

References

  1. Thorel MF. Isolation of Mycobacterium africanum from monkeys. Tubercle. 1980;61:101–4.

    CAS  Article  Google Scholar 

  2. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006;103:2869–73.

    CAS  Article  Google Scholar 

  3. Coscolla M, Gagneux S, Menardo F, et al. Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history. Microb Genom. 2021;7(2):000477.

    CAS  PubMed Central  Google Scholar 

  4. De Jong BC, Antonio M, Gagneux S. Mycobacterium africanum-review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis. 2010;4(9):e744.

    Article  Google Scholar 

  5. Isea-Peña MC, Brezmes-Valdivieso MF, Gonzalez-Velasco MC, Lezcano-Carrera MA, Lopez-Urrutia-Lorente L, Martin-Casabona N, et al. Mycobacterium africanum, an emerging disease in high-income countries? Int J Tuberc Lung Dis. 2012;16:1400–4.

    Article  Google Scholar 

  6. Aldea MJ, Lezcano MA, Esteban A, Bello S, Vila M, et al. Pleuropulmonary tuberculosis caused by Mycobacterium africanum in a White male. Enferm Infecc Microbiol Clin. 1990;8:64–5.

    CAS  PubMed  Google Scholar 

  7. Baril L, Caumes E, Truffot-Pernot C, Bricaire F, Grosset J, et al. Tuberculosis caused by Mycobacterium africanum associated with involvement of the upper and lower respiratory tract, skin, and mucosa. Clin Infect Dis. 1995;21:653–5.

    CAS  Article  Google Scholar 

  8. Petit JC, Lesage D, et al. Bone tuberculosis due to Mycobacterium africanum-2 cases. Nouvelle Presse Med. 1980;9:2845.

    CAS  Google Scholar 

  9. Bhanot N, Badem O, Mathew L, Haran M. Mycobacterium africanum presenting as a brain mass. Infect Dis Clin Pract. 2008;16:327–9.

    Article  Google Scholar 

  10. Remacha Esteras MA, Parra Parra I, Blanco Mercade MD. Disseminated tuberculosis due to Mycobacterium africanum. Arch Bronconeumol. 2003;39:376.

    CAS  Article  Google Scholar 

  11. Pérez-de Pedro I, Bermúdez P, Arter I, Soledad Jiménez M. Orquiepididimitis por Mycobacterium africanum. Enferm Infecc Microbiol Clin. 2008;26(9):600–2.

    Article  Google Scholar 

  12. Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Tuberculous pericarditis: ten-year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol. 1988;11:724–8.

    CAS  Article  Google Scholar 

  13. De Jong BC, Adetifa I, Walther B, et al. Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update. FEMS Immunol Med Microbiol. 2010;58:102–5.

    Article  Google Scholar 

  14. De Jong BC, Hill PC, Aiken A, Awine T, Antonio M, Adetifa IM, Jackson-Sillah DJ, Fox A, Deriemer K, Gagneux S, Borgdorff MW, McAdam KP, Corrah T, Small PM, Adegbola RA. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis. 2008;198(7):1037–43.

    Article  Google Scholar 

  15. Ofori-Anyinam B, Riley AJ, Jobarteh T, et al. Comparative genomics shows differences in the electron transport and carbon metabolic pathways of Mycobacterium africanum relative to Mycobacterium tuberculosis and suggests an adaptation to low oxygen tension. Tuberculosis (Edinb). 2020;120:101899.

    CAS  Article  Google Scholar 

  16. Jong BC, Hill PC, Brookes RH, et al. Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts. J Infect Dis. 2006;193:1279–86.

    Article  Google Scholar 

  17. Cho OH, Park KH, Kim SM, Park SJ, Moon SM, Chong YP, et al. Diagnostic performance of T-SPOT. TB for extrapulmonary tuberculosis according to the site of infection. J Infect. 2011;63(5):362–9.

    Article  Google Scholar 

  18. Bian S, Zhang Y, Zhang L, Shi X, Liu X. Diagnostic value of interferon-γ release assays on pericardial effusion for diagnosis of tuberculous pericarditis. PLoS ONE. 2016;11(10):e0165008.

    Article  Google Scholar 

  19. Grosset J, Decroix G, Sors C. Tuberculosis due to Mycobacterium africanum in African negroes in the Paris area. Rev Tuberc Pneumol (Paris). 1971;35:430–6.

    CAS  Google Scholar 

  20. Mayosi BM, Ntsekhe M, Bosch J, et al. IMPI Trial Investigators. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014;18(12):1121–30.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Iñaki Comas (Tuberculosis Genomics Unit, Biomedicine Institute of Valencia, Valencia, Spain) for contributed to the genomic epidemiologic analysis of M. africanum.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

Preparation of the manuscript (PM, MM, FG, ADLR, MRG, SP, JGA, AB, JL). All authors have read and approved the manuscript to be published. ADLR and MRG contributed to the analysis and identification of M. africanum. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Paula Mascarell.

Ethics declarations

Ethics approval and consent to participate

The treatment for the patient is performed under the tenets of the Declaration of Helsinki.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mascarell, P., de la Rica, A., Padilla, S. et al. Pericarditis caused by Mycobacterium africanum: case report. BMC Infect Dis 22, 628 (2022). https://doi.org/10.1186/s12879-022-07540-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-022-07540-x

Keywords

  • Mycobacterium africanum
  • Mycobacterium tuberculosis complex
  • Tuberculous pericarditis
  • Interferon-gamma release assays
  • Case report